2009
DOI: 10.1016/j.bbrc.2009.06.097
|View full text |Cite
|
Sign up to set email alerts
|

Titanium dioxide nanoparticles induce apoptosis through the JNK/p38-caspase-8-Bid pathway in phytohemagglutinin-stimulated human lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
49
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(53 citation statements)
references
References 22 publications
3
49
1
Order By: Relevance
“…For example, some studies have shown that apoptosis is triggered by TiO 2 NPs. Kang et al (2009) and Zhao et al (2009) reported that TiO 2 NP-induced apoptosis is mediated by the caspase-8/t-Bid pathway, whereas Shi et al (2010) did not. The p53 pathway mediates TiO 2 NPs-induced apoptosis (Kang et al, 2008;Shi et al, 2010;Wu et al, 2010).…”
Section: It Is Critical To Assess Potential Impacts Of Nps Onmentioning
confidence: 99%
“…For example, some studies have shown that apoptosis is triggered by TiO 2 NPs. Kang et al (2009) and Zhao et al (2009) reported that TiO 2 NP-induced apoptosis is mediated by the caspase-8/t-Bid pathway, whereas Shi et al (2010) did not. The p53 pathway mediates TiO 2 NPs-induced apoptosis (Kang et al, 2008;Shi et al, 2010;Wu et al, 2010).…”
Section: It Is Critical To Assess Potential Impacts Of Nps Onmentioning
confidence: 99%
“…For example phytohemagglutininstimulated human lymphocytes during 24 h showed parp cleavage was activated by nano-TiO 2 [35]. On the contrary, we did not observe any apoptotic signature in TiO 2 -NPs treated cell groups ( Figure 3C).…”
Section: Discussionmentioning
confidence: 44%
“…These studies afford correlative evidence, but also are designed to search new possibilities of tumor destruction [52]. Many in vitro experiments confirm the preventing role of Bcl-2 in apoptosis activating in different type of cancer [97].…”
Section: The Role Of P53 and Bcl-2 Family In Apoptosismentioning
confidence: 99%
“…However, in 50% of cancers the p53 gene is disrupted and losses its ability to bind to these proteins. Hence research is continuing on the use of synthetic inhibitors in preclinical and clinical study (Table 1.) [97]. The most of them determined the direction of future clinical development and are promising.…”
Section: The Role Of P53 and Bcl-2 Family In Apoptosismentioning
confidence: 99%